Phase III clinical trial - Appareil pulmonaire

CheckMate 816 (CA209-816)
Appareil pulmonaire
Ouvert depuis le: 10.24.2019
Site: Paris
Public cible
Adulte
Randomized, OpenLabel, Phase 3 Trial of Nivolumab and Ipilimumab Versus Platinum Doublet Chemotherapy in Early Stage NSCLC.
Description de l'essai

The purpose of this study is to determine the safety and effectiveness of nivolumab and ipilimumab compared to chemotherapy in the treatment of Early Stage Non-Small Cell Lung Cancer